■远程医疗的最新进展导致数字检眼镜(DO)在临床环境中的使用增加。这篇综述旨在评估商业上可用的DOs,包括智能手机(SP),桌面,和手持式检眼镜,并评估其应用。
■通过搜索PubMed(pubmed。ncbi.nlm.nih.gov),WebofScience(webofknowledge.com),和科学直接(sciencedirect.com)。搜索术语“数字检眼镜”产生的所有英文论文,\"筛选工具\",“青光眼筛查”,“糖尿病视网膜病变筛查”,“白内障筛查”,和“乳头水肿筛查”进行了审查。纳入了2010年1月至2020年12月期间对人类参与者进行随机临床试验的研究。系统审查中的偏差风险(ROBIS)工具用于评估每篇论文的方法学质量。
■在确定的1307项研究中,35符合纳入和排除标准。ROBIS工具确定29/35研究(82.8%)有低偏倚风险,3/35(8.5%)有中等偏倚风险,3/35(8.5%)的偏倚风险较高.
■由于担心非散瞳眼睛的图像质量以及对从设备捕获的数据的信心,因此继续采用DOs仍然不确定。同样,缺乏使用DOs的指导方针,这使得提供商难以确定其实践的最佳设备并确保适当使用。即便如此,随着技术和实践集成的改进,DOs继续获得认可,尤其是在眼科医生服务不足的地区。
UNASSIGNED: Recent advances in telemedicine have led to increased use of digital ophthalmoscopes (DO) in clinical settings. This
review aims to assess commercially available DOs, including smartphone (SP), desktop, and handheld ophthalmoscopes, and evaluate their applications.
UNASSIGNED: A literature
review was performed by searching PubMed (pubmed.ncbi.nlm.nih.gov), Web of Science (webofknowledge.com), and Science Direct (sciencedirect.com). All English-language papers that resulted from the search terms \"digital ophthalmoscope\", \"screening tool\", \"glaucoma screening\", \"diabetic retinopathy screening\", \"cataract screening\", and \"papilledema screening\" were reviewed. Studies that contained randomized clinical trials with human participants between January 2010 and December 2020 were included. The Risk of Bias in Systematic Reviews (ROBIS) tool was used to assess the methodological quality of each included paper.
UNASSIGNED: Of the 1307 studies identified, 35 met inclusion and exclusion criteria. The ROBIS tool determined that 29/35 studies (82.8%) had a low risk of bias, 3/35 (8.5%) had a moderate risk of bias, and 3/35 (8.5%) had a high risk of bias.
UNASSIGNED: The continued adoption of DOs remains uncertain because of concerns about the image quality for non-mydriatic eyes and the confidence in data captured from the device. Likewise, there is a lack of guidelines for the use of DOs, which makes it difficult for providers to determine the best device for their practice and to ensure appropriate use. Even so, DOs continue to gain acceptance as technology and practice integration improve, especially in underserved areas with limited access to ophthalmologists.